DOCSLIB.ORG

3 Growth Factors

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
3 Growth Factors 3 Growth Factors ... Of vista — Suppose some sight in arriere, through the formative chaos, presuming the growth, fulness, life, now attain’d on the journey; (But I see the road continued, and the journey ever continued;) — Of what was once lacking on earth, and in due time has become supplied ... (Thoughts, 1855, Walt Whitman [1819–1892]) Any cell needs extracellular signals for its growth, proliferation, and survival, among other events. Chemical, mechanical, electrical, and other physical in- teractions of cells with the extracellular matrix yield functional and structural signals for normal cellular activity as well as formation and maintenance of three-dimensional tissues. Environmental chemical signals are transmitted by hormones (Sect. 1.4) and growth factors (Table 3.1), in addition to nervous cues (Sect. 1.1). In the sustained absence of growth factors, cells can undergo apoptosis (Chap. 4). Growth factor withdrawal causes loss in plasmalemmal transporters for nutrients and receptors for extracellular molecules, such as glucose, amino acids, low-density lipoprotein, iron, etc. [305]. Yet, transiently, cells have a defense system against stress for survival. Many growth factors (GF) are molecules, most often proteins, but also lipids, that bind to receptors on the cell surface (Fig. 3.1;Vol.3,Chap.6. Receptors), mainly to activate cellular proliferation and/or differentiation. The terminology currently used comes from the initial discovery context. Many growth factors have a pleiotropic nature. They thus stimulate al- most every cell type, whereas others are specific to particular cell types. The growth factors have functional redundancy, but they can have distinct effects. Their production and activation depend on the balance between inhibitory and stimulatory factors as well as their transport and storage capacities. In M. Thiriet, Control of Cell Fate in the Circulatory and Ventilatory Systems, 177 BBMCVS 2, DOI 10.1007/978-1-4614-0329-6_3, © Springer Science+Business Media, LLC 2012 178 3 Growth Factors Table 3.1. Examples of growth factors that regulate development and homeostasis of blood cells and vessels (Sources: [301–304]; gCSF: granulocyte colony-stimulating factors [CSF3]; gmCSF: granulocyte–macrophage colony-stimulating factors [CSF2]; mCSF: macrophage colony-stimulating factor [CSF1]; EGF: epidermal growth fac- tor; Epo: erythropoietin; FGF: fibroblast growth factor; IGF: insulin-like growth fac- tor; PDGF: platelet-derived growth factor; TGF: transforming growth factor; TNF: tumor-necrosis factor; VEGF: vascular endothelial growth factor; Bϕ: basophil; EC: endothelial cell; Eϕ: eosinophil; FB: fibroblast; Lϕ: lymphocyte; Mϕ: macrophage; Mo: monocyte; Nϕ: neutrophil; RBC: red blood cell [erythrocyte]; SMC: smooth muscle cell; TC: thrombocyte [platelet]). Concentration gradients of growth factors are required for cell chemotaxis. Factor Sources Targets Function gCSF Mϕ,EC Nϕ Hematopoiesis gmCSF Mo, Mϕ,TLϕ,EC,FBMϕ,Nϕ, FB Immunity mCSF T Lϕ,Mϕ Mo, Mϕ Hematopoiesis EGF TC, Mo, Mϕ, FB, EC Cell division, chemotaxis, angiogenesis Epo Kidney RBC Erythropoiesis FGF1,2 Mo, EC, FB, Mϕ FB, EC, Cell division, chemotaxis, SMC angiogenesis IGF Mϕ, FB, TC FB, EC, SMC Cell division, collagen synthesis PDGF EC, SMC, Nϕ,Nϕ,Mo,Mϕ, Cell division, chemotaxis, TC, Mϕ, FB FB, EC, SMC angiogenesis, collagen synthesis, TGFα,β Mϕ,TLϕ,EC, FB,Mϕ, Chemotaxis, angiogenesis, TC, FB Mo, Lϕ, matrix production, EC, SMC healing, inhibition of inflammation TNF Mϕ,TLϕ,Nϕ Mϕ, FB Angiogenesis, inflammation VEGF Mϕ, FB, SMC EC Angiogenesis particular, cell growth is controlled by a balance between growth-promoting and -inhibiting factors. Growth factors promote not only cell division, maturation, and function- ing, but also tissue growth and remodeling. Growth factors act on [307]: (1) growth factor-producing cells (intra- and autocrine effects),1 (2) neigh- 1 Autocrine growth factor is involved in autostimulatory growth control, in which a cell secretes a factor that binds to its receptor, which is also expressed by the 3 Growth Factors 179 GFR GPCR or RTK PIP2 Src PLC IP3 DAG Grb Sos Rac NRTK PI3K PAK PKC Ras RasGRP RacGEF JUN2K Raf Rac GTP Rac/Ras/Rho PKB JNK GAP MAP2K RhoA GTP P GEF GDP PLD Rac/Ras/Rho ERK GDI GTPase−−GDI Figure 3.1. The growth factor receptor and biochemical cascades (Source: [306]). Growth factor-bound receptor (GFR) activates the adaptor GRB coupled to the guanine nucleotide (GDP-to-GTP)-exchange factor (GEF) SOS (GRB–SOS com- plex), and subsequently Ras GTPase, Raf kinase, and mitogen-activated pro- tein kinase kinase (MAP2K) successively, and then extracellular regulated kinase (ERK) on the one hand (MAPK module), and small GTPases Rac and RhoA, and phospholipase-D (PLD) on the other hand. Ligand-bound receptors also acti- vate among other pathways: (1) phosphatidylinositol 3-kinase (PI3K) and protein kinase-B (PKB), (2) Src kinase, (3) Rac GTPase and Jun N-terminal kinase (JNK), and (4) phospholipase-C (PLC). (Lower right corner) Activation–inactivation cy- cle of small, monomeric guanosine triphosphatases (GTPase; e.g., Rac, Ras, and Rho; GTPaseGTP,GTPaseGDP: active and inactive forms) by GEF and GTPase- activating protein (GAP) and sequestration by guanine nucleotide-dissociation in- hibitors (GDI). boring cells (paracrine effect),2 (3) connecting cells (juxtacrine effect), and (4) distant cells after blood transport (endocrine effect). The set of growth factors includes cytokines and chemokines (chemotactic cytokines). Cytokines,3 or immunocytokines, are growth factors that modulate producing cell. This autogenous loop creates a substance that acts back on the cells that produce it. 2 Paracrine growth factor influences the growth and functional activities of sur- rounding cells expressing the corresponding receptor. Paracrine growth factors modulate the microenvironment. In particular, they are involved in angiogene- sis, stroma formation, modulation of immune response, activation of proteolytic enzymes, etc. 3 κυτoς: hollow object [organ] and also [like Latin cutis] envelope [by extension cell]; κιν ω:tomove. 180 3 Growth Factors activities of immunocytes. These immunomodulators, or immunotransmitters, are secreted primarily by leukocytes, either by lymphocytes (lymphokines) or monocytes and macrophages (monokines). Hence, cytokines are separated from other regulatory peptides that modulate the proliferation and activities of non-immunocytes. However, some cytokines are produced by almost the entire cell spectrum.4 Cytokines stimulate both the humoral (antibody) and cellular immune responses. Among lymphokines, interleukins (IL) are growth factors targeted to hematopoietic cells. Interferons (Ifn) are glycoproteic cytokines produced by cells of the immune system in response to foreign agents (viruses, bacteria, parasites, tumor cells). immunocytes have reciprocal activations.5 Organ development is controlled by a set of growth factors and their regula- tors (e.g., Notch). Vascular endothelial growth factor-A is the most important agent required for vasculogenesis (migration and differentiation of angioblasts and formation of primitive vascular structures), as well as angiogenesis before and after birth and vessel remodeling (Vol. 5 – Chap. 10. Vasculature Growth). Growth factors yield cell response using several regulated mechanisms, the so- called signaling pathways (Vol. 3 – Chap. 1. Signal Transduction) that lead up to substance release as well as gene expression and production of alternatively spliced variants (Vol. 1 – Chap. 5. Protein Synthesis). 3.1 Connective Tissue Growth Factor Connective tissue growth factor (CTGF)6 is a member of the CCN gene family that is activated by several factors such as transforming growth factor-β. The CCN family comprises 6 known members [308]: cysteine-rich protein- 61 (CyR61 or CCN1), connective tissue growth factor (CTGF or CCN2), nephroblastoma overexpressed protein (NOv or CCN3), and Wnt-induced se- creted protein-1 (WISP1 or CCN4), -2 (WISP2 or CCN5), and -3 (WISP3 or CCN6; Table 3.2).7 These proteins regulate cell survival, differentiation, proliferation, adhesion, and migration, as well as extracellular matrix produc- tion. Therefore, members of the CCN family are involved in implantation, 4 Heart expresses cytokines, particularly tumor-necrosis factors TNFα and -β, interleukin-1α and -1β, -2 to -6, and -10, as well as interferon-γ. 5 T lymphocytes synthesize lymphokines (gmCSF, IL3, and Ifn) that stimulate macrophages. Afterward, macrophages produce monokines (IL1) that activate T lymphocytes. 6 A.k.a. hypertrophic chondrocyte-specific protein HCS24, CCN family member CCN2, and insulin-like growth factor-binding protein IBP8 and IGFBP8. 7 Alias CCN comes from the first 3 members of the family CyR61, CTGF, and NOv. These multimodular proteins contain an insulin-like growth factor (IGF)- binding (module 1), a von Willebrand type-C (module 2), a thrombospondin-1 domain (module 3), and a C-terminus (module 4) [308]. 3.1 Connective Tissue Growth Factor 181 Table 3.2. Members of the CCN family (Source: [309]; CEF: chicken embryo fi- broblast; CTGF: connective tissue growth factor; CTGFL: connective tissue growth factor-like protein; CyR: cysteine-rich protein; ELM: expressed low in metastasis; FISP: fibroblast-inducible secreted protein; HCS: hypertrophic chondrocyte-specific gene product; HICP: heparin-inducible CCN-like protein; IGFBP: insulin-like growth factor-binding protein; IGFBPRP: IGFBP-related protein; NOv: nephrob- lastoma overexpressed protein: WISP: Wnt-inducible signaling
Load more

Recommended publications
  • Development and Maintenance of Epidermal Stem Cells in Skin Adnexa
    International Journal of Molecular Sciences Review Development and Maintenance of Epidermal Stem Cells in Skin Adnexa Jaroslav Mokry * and Rishikaysh Pisal Medical Faculty, Charles University, 500 03 Hradec Kralove, Czech Republic; [email protected] * Correspondence: [email protected] Received: 30 October 2020; Accepted: 18 December 2020; Published: 20 December 2020 Abstract: The skin surface is modified by numerous appendages. These structures arise from epithelial stem cells (SCs) through the induction of epidermal placodes as a result of local signalling interplay with mesenchymal cells based on the Wnt–(Dkk4)–Eda–Shh cascade. Slight modifications of the cascade, with the participation of antagonistic signalling, decide whether multipotent epidermal SCs develop in interfollicular epidermis, scales, hair/feather follicles, nails or skin glands. This review describes the roles of epidermal SCs in the development of skin adnexa and interfollicular epidermis, as well as their maintenance. Each skin structure arises from distinct pools of epidermal SCs that are harboured in specific but different niches that control SC behaviour. Such relationships explain differences in marker and gene expression patterns between particular SC subsets. The activity of well-compartmentalized epidermal SCs is orchestrated with that of other skin cells not only along the hair cycle but also in the course of skin regeneration following injury. This review highlights several membrane markers, cytoplasmic proteins and transcription factors associated with epidermal SCs. Keywords: stem cell; epidermal placode; skin adnexa; signalling; hair pigmentation; markers; keratins 1. Epidermal Stem Cells as Units of Development 1.1. Development of the Epidermis and Placode Formation The embryonic skin at very early stages of development is covered by a surface ectoderm that is a precursor to the epidermis and its multiple derivatives.
    [Show full text]
  • Fgf17b and FGF18 Have Different Midbrain Regulatory Properties from Fgf8b Or Activated FGF Receptors Aimin Liu1,2, James Y
    Research article 6175 FGF17b and FGF18 have different midbrain regulatory properties from FGF8b or activated FGF receptors Aimin Liu1,2, James Y. H. Li2, Carrie Bromleigh2, Zhimin Lao2, Lee A. Niswander1 and Alexandra L. Joyner2,* 1Howard Hughes Medical Institute, Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA 2Howard Hughes Medical Institute and Skirball Institute of Biomolecular Medicine, Departments of Cell Biology, and Physiology and Neuroscience, NYU School of Medicine, New York, NY 10016, USA *Author for correspondence (e-mail: [email protected]) Accepted 28 August 2003 Development 130, 6175-6185 Published by The Company of Biologists 2003 doi:10.1242/dev.00845 Summary Early patterning of the vertebrate midbrain and region in the midbrain, correlating with cerebellum cerebellum is regulated by a mid/hindbrain organizer that development. By contrast, FGF17b and FGF18 mimic produces three fibroblast growth factors (FGF8, FGF17 FGF8a by causing expansion of the midbrain and and FGF18). The mechanism by which each FGF upregulating midbrain gene expression. This result is contributes to patterning the midbrain, and induces a consistent with Fgf17 and Fgf18 being expressed in the cerebellum in rhombomere 1 (r1) is not clear. We and midbrain and not just in r1 as Fgf8 is. Third, analysis of others have found that FGF8b can transform the midbrain gene expression in mouse brain explants with beads soaked into a cerebellum fate, whereas FGF8a can promote in FGF8b or FGF17b showed that the distinct activities of midbrain development. In this study we used a chick FGF17b and FGF8b are not due to differences in the electroporation assay and in vitro mouse brain explant amount of FGF17b protein produced in vivo.
    [Show full text]
  • Fog2 Is Critical for Cardiac Function and Maintenance of Coronary Vasculature in the Adult Mouse Heart
    Fog2 is critical for cardiac function and maintenance of coronary vasculature in the adult mouse heart Bin Zhou, … , Sergei G. Tevosian, William T. Pu J Clin Invest. 2009;119(6):1462-1476. https://doi.org/10.1172/JCI38723. Research Article Cardiology Aberrant transcriptional regulation contributes to the pathogenesis of both congenital and adult forms of heart disease. While the transcriptional regulator friend of Gata 2 (FOG2) is known to be essential for heart morphogenesis and coronary development, its tissue-specific function has not been previously investigated. Additionally, little is known about the role of FOG2 in the adult heart. Here we used spatiotemporally regulated inactivation of Fog2 to delineate its function in both the embryonic and adult mouse heart. Early cardiomyocyte-restricted loss of Fog2 recapitulated the cardiac and coronary defects of the Fog2 germline murine knockouts. Later cardiomyocyte-restricted loss ofF og2 (Fog2MC) did not result in defects in cardiac structure or coronary vessel formation. However, Fog2MC adult mice had severely depressed ventricular function and died at 8–14 weeks. Fog2MC adult hearts displayed a paucity of coronary vessels, associated with myocardial hypoxia, increased cardiomyocyte apoptosis, and cardiac fibrosis. Induced inactivation of Fog2 in the adult mouse heart resulted in similar phenotypes, as did ablation of the FOG2 interaction with the transcription factor GATA4. Loss of the FOG2 or FOG2-GATA4 interaction altered the expression of a panel of angiogenesis-related genes. Collectively, our data indicate that FOG2 regulates adult heart function and coronary angiogenesis. Find the latest version: https://jci.me/38723/pdf Research article Fog2 is critical for cardiac function and maintenance of coronary vasculature in the adult mouse heart Bin Zhou,1,2 Qing Ma,1 Sek Won Kong,1 Yongwu Hu,1,3 Patrick H.
    [Show full text]
  • ARTICLES Fibroblast Growth Factors 1, 2, 17, and 19 Are The
    0031-3998/07/6103-0267 PEDIATRIC RESEARCH Vol. 61, No. 3, 2007 Copyright © 2007 International Pediatric Research Foundation, Inc. Printed in U.S.A. ARTICLES Fibroblast Growth Factors 1, 2, 17, and 19 Are the Predominant FGF Ligands Expressed in Human Fetal Growth Plate Cartilage PAVEL KREJCI, DEBORAH KRAKOW, PERTCHOUI B. MEKIKIAN, AND WILLIAM R. WILCOX Medical Genetics Institute [P.K., D.K., P.B.M., W.R.W.], Cedars-Sinai Medical Center, Los Angeles, California 90048; Department of Obstetrics and Gynecology [D.K.] and Department of Pediatrics [W.R.W.], UCLA School of Medicine, Los Angeles, California 90095 ABSTRACT: Fibroblast growth factors (FGF) regulate bone growth, (G380R) or TD (K650E) mutations (4–6). When expressed at but their expression in human cartilage is unclear. Here, we deter- physiologic levels, FGFR3-G380R required, like its wild-type mined the expression of entire FGF family in human fetal growth counterpart, ligand for activation (7). Similarly, in vitro cul- plate cartilage. Using reverse transcriptase PCR, the transcripts for tivated human TD chondrocytes as well as chondrocytes FGF1, 2, 5, 8–14, 16–19, and 21 were found. However, only FGF1, isolated from Fgfr3-K644M mice had an identical time course 2, 17, and 19 were detectable at the protein level. By immunohisto- of Fgfr3 activation compared with wild-type chondrocytes and chemistry, FGF17 and 19 were uniformly expressed within the showed no receptor activation in the absence of ligand (8,9). growth plate. In contrast, FGF1 was found only in proliferating and hypertrophic chondrocytes whereas FGF2 localized predominantly to Despite the importance of the FGF ligand for activation of the resting and proliferating cartilage.
    [Show full text]
  • Cytokine Nomenclature
    RayBiotech, Inc. The protein array pioneer company Cytokine Nomenclature Cytokine Name Official Full Name Genbank Related Names Symbol 4-1BB TNFRSF Tumor necrosis factor NP_001552 CD137, ILA, 4-1BB ligand receptor 9 receptor superfamily .2. member 9 6Ckine CCL21 6-Cysteine Chemokine NM_002989 Small-inducible cytokine A21, Beta chemokine exodus-2, Secondary lymphoid-tissue chemokine, SLC, SCYA21 ACE ACE Angiotensin-converting NP_000780 CD143, DCP, DCP1 enzyme .1. NP_690043 .1. ACE-2 ACE2 Angiotensin-converting NP_068576 ACE-related carboxypeptidase, enzyme 2 .1 Angiotensin-converting enzyme homolog ACTH ACTH Adrenocorticotropic NP_000930 POMC, Pro-opiomelanocortin, hormone .1. Corticotropin-lipotropin, NPP, NP_001030 Melanotropin gamma, Gamma- 333.1 MSH, Potential peptide, Corticotropin, Melanotropin alpha, Alpha-MSH, Corticotropin-like intermediary peptide, CLIP, Lipotropin beta, Beta-LPH, Lipotropin gamma, Gamma-LPH, Melanotropin beta, Beta-MSH, Beta-endorphin, Met-enkephalin ACTHR ACTHR Adrenocorticotropic NP_000520 Melanocortin receptor 2, MC2-R hormone receptor .1 Activin A INHBA Activin A NM_002192 Activin beta-A chain, Erythroid differentiation protein, EDF, INHBA Activin B INHBB Activin B NM_002193 Inhibin beta B chain, Activin beta-B chain Activin C INHBC Activin C NM005538 Inhibin, beta C Activin RIA ACVR1 Activin receptor type-1 NM_001105 Activin receptor type I, ACTR-I, Serine/threonine-protein kinase receptor R1, SKR1, Activin receptor-like kinase 2, ALK-2, TGF-B superfamily receptor type I, TSR-I, ACVRLK2 Activin RIB ACVR1B
    [Show full text]
  • Gene Expression Analysis Identifies Potential Biomarkers of Neurofibromatosis Type 1 Including Adrenomedullin
    Published OnlineFirst August 25, 2010; DOI: 10.1158/1078-0432.CCR-10-0613 Clinical Imaging, Diagnosis, Prognosis Cancer Research Gene Expression Analysis Identifies Potential Biomarkers of Neurofibromatosis Type 1 Including Adrenomedullin Trent R. Hummel1, Walter J. Jessen1, Shyra J. Miller1, Lan Kluwe4, Victor F. Mautner4, Margaret R. Wallace5, Conxi Lázaro6, Grier P. Page7, Paul F. Worley8, Bruce J. Aronow2, Elizabeth K. Schorry3, and Nancy Ratner1 Abstract Purpose: Plexiform neurofibromas (pNF) are Schwann cell tumors found in a third of individuals with neurofibromatosis type 1 (NF1). pNF can undergo transformation to malignant peripheral nerve sheath tumors (MPNST). There are no identified serum biomarkers of pNF tumor burden or transformation to MPNST. Serum biomarkers would be useful to verify NF1 diagnosis, monitor tumor burden, and/or detect transformation. Experimental Design: We used microarray gene expression analysis to define 92 genes that encode putative secreted proteins in neurofibroma Schwann cells, neurofibromas, and MPNST. We validated dif- ferential expression by quantitative reverse transcription-PCR, Western blotting, and ELISA assays in cell conditioned medium and control and NF1 patient sera. Results: Of 13 candidate genes evaluated, only adrenomedullin (ADM) was confirmed as differentially expressed and elevated in serum of NF1 patients. ADM protein concentrati on was further elevated in serum of a small sampling of NF1 patients with MPNST. MPNST cell conditioned medium, containing ADM and hepatocyte growth factor, stimulated MPNST migration and endothelial cell proliferation. Conclusions: Thus, microarray analysis identifies potential serum biomarkers for disease, and ADM is a serum biomarker of NF1. ADM serum levels do not seem to correlate with the presence of pNFs but may be a biomarker of transformation to MPNST.
    [Show full text]
  • Disruption of Fibroblast Growth Factor Signal
    Cancer Therapy: Preclinical Disruption of Fibroblast Growth Factor Signal Pathway Inhibits the Growth of Synovial Sarcomas: Potential Application of Signal Inhibitors to MolecularTarget Therapy Ta t s u y a I s hi b e , 1, 2 Tomitaka Nakayama,2 Ta k e s h i O k a m o t o, 1, 2 Tomoki Aoyama,1Koichi Nishijo,1, 2 Kotaro Roberts Shibata,1, 2 Ya s u ko Shim a ,1, 2 Satoshi Nagayama,3 Toyomasa Katagiri,4 Yusuke Nakamura, 4 Takashi Nakamura,2 andJunya Toguchida 1 Abstract Purpose: Synovial sarcoma is a soft tissue sarcoma, the growth regulatory mechanisms of which are unknown.We investigatedthe involvement of fibroblast growth factor (FGF) signals in synovial sarcoma andevaluatedthe therapeutic effect of inhibiting the FGF signal. Experimental Design:The expression of 22 FGF and4 FGF receptor (FGFR) genes in18prima- ry tumors andfive cell lines of synovial sarcoma were analyzedby reverse transcription-PCR. Effects of recombinant FGF2, FGF8, andFGF18 for the activation of mitogen-activatedprotein kinase (MAPK) andthe growth of synovial sarcoma cell lines were analyzed.Growth inhibitory effects of FGFR inhibitors on synovial sarcoma cell lines were investigated in vitro and in vivo. Results: Synovial sarcoma cell lines expressedmultiple FGF genes especially those expressed in neural tissues, among which FGF8 showedgrowth stimulatory effects in all synovial sarcoma cell lines. FGF signals in synovial sarcoma induced the phosphorylation of extracellular signal ^ regulatedkinase (ERK1/2) andp38MAPK but not c-Jun NH 2-terminal kinase. Disruption of the FGF signaling pathway in synovial sarcoma by specific inhibitors of FGFR causedcell cycle ar- rest leading to significant growth inhibition both in vitro and in vivo.Growthinhibitionbythe FGFR inhibitor was associatedwith a down-regulation of phosphorylatedERK1/2 but not p38MAPK, andan ERK kinase inhibitor also showedgrowth inhibitory effects for synovial sar- coma, indicating that the growth stimulatory effect of FGF was transmitted through the ERK1/2.
    [Show full text]
  • FGF14 Regulates Presynaptic Ca2+ Channels and Synaptic Transmission
    Cell Reports Article FGF14 Regulates Presynaptic Ca2+ Channels and Synaptic Transmission Haidun Yan,1,3 Juan L. Pablo,2,3 and Geoffrey S. Pitt1,2,3,* 1Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA 2Department of Neurobiology, Duke University Medical Center, Durham, NC 27710, USA 3Ion Channel Research Unit, Duke University Medical Center, Durham, NC 27710, USA *Correspondence: [email protected] http://dx.doi.org/10.1016/j.celrep.2013.06.012 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited. SUMMARY data pinpointed FGF14 as the locus for spinocerebellar ataxia 27 (SCA27). Fibroblast growth factor homologous factors (FHFs) Focus on FHF regulation of neuronal excitability began when are not growth factors, but instead bind to voltage- Fgf14–/– mice showed ataxia (Wang et al., 2002), providing + gated Na channels (NaV) and regulate their function. a basis for exploring the implications of a linkage analysis that Mutations in FGF14, an FHF that is the locus for identified a F150S missense mutation in a ‘‘b’’ splice variant of F150S F145S spinocerebellar ataxia 27 (SCA27), are believed to FGF14 (FGF14b ; termed FGF14 in some studies that be pathogenic because of a dominant-negative used numbering based on the alternatively spliced FGF14a variant) as the etiology of the autosomal-dominant SCA27 in reduction of Na currents in cerebellar granule cells. V an extended Dutch family (van Swieten et al., 2003).
    [Show full text]
  • Pathophysiological Roles of FGF Signaling in the Heart
    MINI REVIEW ARTICLE published: 06 September 2013 doi: 10.3389/fphys.2013.00247 Pathophysiological roles of FGF signaling in the heart Nobuyuki Itoh* and Hiroya Ohta Department of Genetic Biochemistry, Kyoto University Graduate School of Pharmaceutical Sciences, Kyoto, Japan Edited by: Cardiac remodeling progresses to heart failure, which represents a major cause of Marcel van der Heyden, University morbidity and mortality. Cardiomyokines, cardiac secreted proteins, may play roles Medical Center, Netherlands in cardiac remodeling. Fibroblast growth factors (FGFs) are secreted proteins with Reviewed by: diverse functions, mainly in development and metabolism. However, some FGFs play Marcel van der Heyden, University Medical Center, Netherlands pathophysiological roles in cardiac remodeling as cardiomyokines. FGF2 promotes cardiac Christian Faul, University of Miami hypertrophy and fibrosis by activating MAPK signaling through the activation of FGF Miller School of Medicine, USA receptor (FGFR) 1c. In contrast, FGF16 may prevent these by competing with FGF2 for the *Correspondence: binding site of FGFR1c. FGF21 prevents cardiac hypertrophy by activating MAPK signaling Nobuyuki Itoh, Department of through the activation of FGFR1c with β-Klotho as a co-receptor. In contrast, FGF23 Genetic Biochemistry, Kyoto α University Graduate School of induces cardiac hypertrophy by activating calcineurin/NFAT signaling without Klotho. Pharmaceutical Sciences, These FGFs play crucial roles in cardiac remodeling via distinct action mechanisms. These Yoshida-Shimoadachi, Sakyo, findings provide new insights into the pathophysiological roles of FGFs in the heart and Kyoto 606-8501, Japan may provide potential therapeutic strategies for heart failure. e-mail: itohnobu@ pharm.kyoto-u.ac.jp Keywords: FGF, heart, hypertrophy, fibrosis, heart failure, cardiomyokine INTRODUCTION mice and humans, respectively.
    [Show full text]
  • Insulin–Insr Signaling Drives Multipotent Progenitor Differentiation Toward Lymphoid Lineages
    Article Insulin–InsR signaling drives multipotent progenitor differentiation toward lymphoid lineages Pengyan Xia,1* Shuo Wang,1* Ying Du,1 Guanling Huang,1,2 Takashi Satoh,3 Shizuo Akira,3 and Zusen Fan1 1Key Laboratory of Infection and Immunity of CAS, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China 2University of Chinese Academy of Sciences, Beijing 100049, China 3Department of Host Defense, Research Institute for Microbial Diseases (RIMD), Osaka University, Suita, Osaka 565-0871, Japan The lineage commitment of HSCs generates balanced myeloid and lymphoid populations in hematopoiesis. However, the un- derlying mechanisms that control this process remain largely unknown. Here, we show that insulin–insulin receptor (InsR) signaling is required for lineage commitment of multipotent progenitors (MPPs). Deletion of Insr in murine bone marrow causes skewed differentiation of MPPs to myeloid cells. mTOR acts as a downstream effector that modulates MPP differentiation. mTOR activates Stat3 by phosphorylation at serine 727 under insulin stimulation, which binds to the promoter of Ikaros, lead- ing to its transcription priming. Our findings reveal that the insulin–InsR signaling drives MPP differentiation into lymphoid lineages in early lymphopoiesis, which is essential for maintaining a balanced immune system for an individual organism. Hematopoiesis is the process of producing all compo- Insulin, as the primary anabolic hormone, modulates a nents of the blood system from hematopoietic stem cells variety of physiological processes, including growth, differ- (HSCs; Naik et al., 2013; Mendelson and Frenette, 2014; entiation, apoptosis, and synthesis and breakdown of lipid, Walter et al., 2015). HSCs are quiescent, self-renewable pro- protein, and glucose (Samuel and Shulman, 2012).
    [Show full text]
  • Decorin, a Growth Hormone-Regulated Protein in Humans
    178:2 N Bahl and others Growth hormone increases 178:2 145–152 Clinical Study decorin Decorin, a growth hormone-regulated protein in humans Neha Bahl1,2, Glenn Stone3, Mark McLean2, Ken K Y Ho1,4 and Vita Birzniece1,2,5 1Garvan Institute of Medical Research, Sydney, New South Wales, Australia, 2School of Medicine, Western Sydney Correspondence University, Blacktown Clinical School and Research Centre, Blacktown Hospital, Blacktown, New South Wales, should be addressed Australia, 3School of Computing, Engineering and Mathematics, Western Sydney University, Penrith, New South to V Birzniece Wales, Australia, 4Centres of Health Research, Princess Alexandra Hospital, Brisbane, Queensland, Australia, and Email 5School of Medicine, University of New South Wales, New South Wales, Australia v.birzniece@westernsydney. edu.au Abstract Context: Growth hormone (GH) stimulates connective tissue and muscle growth, an effect that is potentiated by testosterone. Decorin, a myokine and a connective tissue protein, stimulates connective tissue accretion and muscle hypertrophy. Whether GH and testosterone regulate decorin in humans is not known. Objective: To determine whether decorin is stimulated by GH and testosterone. Design: Randomized, placebo-controlled, double-blind study. Participants and Intervention: 96 recreationally trained athletes (63 men, 33 women) received 8 weeks of treatment followed by a 6-week washout period. Men received placebo, GH (2 mg/day), testosterone (250 mg/week) or combination. Women received either placebo or GH (2 mg/day). Main outcome measure: Serum decorin concentration. Results: GH treatment significantly increased mean serum decorin concentration by 12.7 ± 4.2%; P < 0.01. There was a gender difference in the decorin response to GH, with greater increase in men than in women (∆ 16.5 ± 5.3%; P < 0.05 compared to ∆ 9.4 ± 6.5%; P = 0.16).
    [Show full text]
  • New Insight of Some Extracellular Matrix Molecules in Beef Muscles
    New insight of some extracellular matrix molecules in beef muscles. Relationships with sensory qualities Annabelle Dubost, Didier Micol, Claire Lethias, Anne Listrat To cite this version: Annabelle Dubost, Didier Micol, Claire Lethias, Anne Listrat. New insight of some extracel- lular matrix molecules in beef muscles. Relationships with sensory qualities. animal, Pub- lished by Elsevier (since 2021) / Cambridge University Press (until 2020), 2016, 10 (5), pp.1-8. 10.1017/S1751731115002396. hal-02629905 HAL Id: hal-02629905 https://hal.inrae.fr/hal-02629905 Submitted on 27 May 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Animal, page 1 of 8 © The Animal Consortium 2015 animal doi:10.1017/S1751731115002396 New insight of some extracellular matrix molecules in beef muscles. Relationships with sensory qualities A. Dubost1, D. Micol1, C. Lethias2 and A. Listrat1† 1Institut National de la Recherche Agronomique (INRA), UMR1213 Herbivores, F-63122 Saint-Genès-Champanelle, France; ²Institut de Biologie et Chimie des Protéines (IBCP), FRE 3310 DyHTIT, Passage du Vercors, 69367 Lyon, Cedex 07, France (Received 4 December 2014; Accepted 28 September 2015) The aim of this study was to highlight the relationships between decorin, tenascin-X and type XIV collagen, three minor molecules of extracellular matrix (ECM), with some structural parameters of connective tissue and its content in total collagen, its cross-links (CLs) and its proteoglycans (PGs).
    [Show full text]